Evaluation of the Vitek System to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime

Diagnostic Microbiology and Infectious Disease

Volumn 32, Issue 2, 1998, Pages 107-110

  Jones, Ronald N ^a   Biedenbach, Douglas J ^a   Marshall, Steven A ^a   Pfaller, Michael A ^a   Doern, Gary V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHORT SURVEY;

EID: 0031789819     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00051-0     Document Type: Article

References (17)

1. Biedenbach D.J., Jones R.N. Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam. Diagn Microbiol Infect Dis. 21:1995;57-60.
2. Bolmstrom A., Arvidson S., Ericson M., Karlsson A. A novel technique for direct quantification of antimicrobial susceptibility of microorganisms (Abstr. 1209). 28th Interscience Conference Antimicrobial Agents and Chemotherapy, Los Angeles, CA, 1988. 1988;American Society for Microbiology, Washington, DC.
3. Jones R.N., Salazar J.C., Pfaller M.A., Doern G.V. Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the Etest method. Diagn Microbiol Infect Dis. 29:1997;265-272.
4. Ferraro M.J., Jorgensen J.H. Instrument-based antibacterial susceptibility testing. Manual of Clinical Microbiology. 6th ed. 1995;1379-1384 American Society for Microbiology, Washington, DC.
5. Jones R.N. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med. 100:(suppl 6A):1996;3S-12S.
6. Jones R.N., Dudley M.N. Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam analysis of the correlations between in vitro test results and clinical response . Diagn Microbiol Infect Dis. 28:1997;5-18.
7. Jones R.N., Marshall S.A., Zerva L. Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methods. Diagn Microbiol Infect Dis. 28:1997;35-40.
8. Jones R.N., Pfaller M.A., Doern G.V., Erwin M.E., Hollis R.J. Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs a 1997 surveillance trial in 102 medical centers in the United States . Diagn Microbiol Infect Dis. 30:1998;215-228.
9. Jorgensen J.H., Ferraro M.J. Antimicrobial susceptibility testing general principles and contemporary practices . Clin Infect Dis. 26:1998;973-980.
10. Kessler R.E., Fung-Tomc J. Susceptibility of bacterial isolates to β-lactam antibiotics from U.S. clinical trials over a 5-year period. Am J Med. 100:(suppl 6A):1996;13S-19S.
11. Marshall S.A. Serious interpretive error among three commercial systems for susceptibility testing of aztreonam. Diagn Microbiol Infect Dis. 22:1995;249-251.
12. Performance Standards for Antimicrobial Disk Susceptibility Tests Approved Standard M2-A6 . 6th ed. 1997;NCCLS, Wayne, PA.
13. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically Approved Standard M7-A4 . 4th ed. 1997;NCCLS, Wayne, PA.
14. Performance Standards for Antimicrobial Susceptibility Testing, 8th International Supplement M100-S8. 1998;NCCLS, Wayne, PA.
15. Ramphal R., Gucalp R., Rotstein C., Cimino M., Oblon D. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Am J Med. 100:(suppl 6A):1996;83S-89S.
16. Schrank J.H. Jr, Kelley J.W., McAllister C.K. Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with Gram-negative bacteremia. Clin Infect Dis. 20:1995;56-58.
17. Pfaller M.A., Jones R.N., Doern G.V. Multicenter evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Venezuela using the Etest method. Diagn Microbiol Infect Dis. 30:1998;45-52.